Story tips from the Department of Energy's Oak Ridge National Laboratory, Dec...(y material for photovoltaic solar cells;...)
Navigation Links
Story tips from the Department of Energy's Oak Ridge National Laboratory, December 2007
Date:12/10/2007
y material for photovoltaic solar cells; continued testing of a new stainless steel alloy with improved high temperature performance for use in reduced-emission diesel and gasoline engine turbochargers; and a lower cost, more energy efficient manufacturing process known as high magnetic field processing for next-generation materials.
[Contact: Larisa M. Brass, (865) 574-4163; brasslm@ornl.gov]
'/>"/>
| Contact: Ron Walli wallira@ornl.gov 865-576-0226 DOE/Oak Ridge National Laboratory Source:Eurekalert |
Related biology news :
1. Story ideas from the Journal of Lipid Research
2. Story tips from the US Department of Energys Oak Ridge National Laboratory, September 2007
3. Satellites witness lowest Arctic ice coverage in history
4. Census of protein architectures offers new view of history of life
5. New study sheds light on Galápagos hawk evolutionary history
6. Microfossils disclose geologic history of eastern California
7. Story ideas from Molecular & Cellular Proteomics
8. Story tips from the Department of Energys Oak Ridge National Laboratory, October 2007
9. Story ideas from the Journal of Biological Chemistry
10. Rebuilding the evolutionary history of HIV-1 unravels a complex loop
11. Nanotechnology and the media: The inside story
Post Your Comments:
Breaking Biology News(10 mins):Einstein receives high-risk/high-reward cancer research funding 2Einstein receives high-risk/high-reward cancer research funding 3Scientists discover gene module underlying atherosclerosis development 2Medicinal products susceptible to dose dumping should be fully tested 58148 157 college presidents declare support for public access to publicly funded research in the US 10057 157 college presidents declare support for public access to publicly funded research in the US 10057 257 college presidents declare support for public access to publicly funded research in the US 10057 3Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 1Cardiogenesis Announces Successful Symposium at the Transcatheter Cardiovascular Therapeutics 28TCT 29 Meeting 58143 2
Other Biology News:Climate change could be impetus for wars, other conflicts, expert says 2Climate change could be impetus for wars, other conflicts, expert says 3Climate change could be impetus for wars, other conflicts, expert says 4Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 2Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 3Senescence in liver cells is found by CSHL scientists to help limit acute tissue damage 4Tahitian vanilla originated in Maya forests, says UC Riverside botanist 2Tahitian vanilla originated in Maya forests, says UC Riverside botanist 3
Breaking Biology Technology:Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 2Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2
[0] Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)[0] Nikon Corporation Acquires License From Harvard University For 'STORM' Super Resolution Microscopy -- Will Create Innovative New 'N-STORM' Microscope[0] Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced[0] Caliper Life Sciences Launches Living Image(R) 4.0 Software
Other Biology Technology:NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 2NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 3NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 4NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza Strains 5Children's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership Program 2Bedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers 2
NOVAVAX Announces Publication of a Preclinical Study Demonstrating that a Virus-like Particle Vaccine Provided Protection Against Highly Pathogenic H1N1 and H5N1 Influenza StrainsChildren's Memorial Research Center, Chicago Becomes a Member of GeneGo's MetaMiner Stem Cell Partnership ProgramBedford Laboratories(TM) to Begin Shipping Fluconazole Injection in PVC Flexible Containers
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |